Amalgamated Bank Bristol Myers Squibb CO Transaction History

Amalgamated Bank

$11.7 Billion
Q2 2024

A detailed history of Amalgamated Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Amalgamated Bank holds 409,901 shares of BMY stock, worth $21.8 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

409,901

Previous 422,183 2.91%

Holding current value

$21.8 Million

Previous $22.9 Million 25.65%

% of portfolio

0.14%

Previous 0.2%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $494,350 - $650,823	-12,282 Reduced 2.91%	409,901 $17 Million
Q1 2024 Apr 23, 2024	SELL	$47.98 - $54.4 $3.46 Million - $3.92 Million	-72,138 Reduced 14.59%	422,183 $22.9 Million
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $1.75 Million - $2.09 Million	-36,084 Reduced 6.8%	494,321 $25.4 Million
Q3 2023 Nov 08, 2023	SELL	$57.89 - $64.73 $661,682 - $739,863	-11,430 Reduced 2.11%	530,405 $30.8 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $3.42 Million - $3.8 Million	-53,678 Reduced 9.01%	541,835 $34.7 Million
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $2.45 Million - $2.78 Million	37,264 Added 6.68%	595,513 $41.3 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $1.29 Million - $1.53 Million	-18,861 Reduced 3.27%	558,249 $40.2 Million
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $4,342 - $2.57 Million	33,400 Added 6.14%	577,110 $41 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $2.5 Million - $2.75 Million	-34,359 Reduced 5.94%	543,710 $41.9 Million
Q1 2022 Jun 30, 2022	SELL	$61.48 - $73.72 $2.95 Million - $3.54 Million	-47,972 Reduced 7.66%	578,069 $42.2 Million
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $1.22 Million - $1.42 Million	22,744 Added 3.77%	626,041 $39 Million
Q3 2021 Oct 29, 2021	SELL	$59.17 - $69.31 $1.49 Million - $1.74 Million	-25,101 Reduced 3.99%	603,297 $35.7 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $30.9 Million - $33.7 Million	499,210 Added 386.42%	628,398 $42 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $325,598 - $366,202	-5,487 Reduced 4.07%	129,188 $8.16 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $23,731 - $26,891	-411 Reduced 0.3%	134,675 $8.35 Million
Q3 2020 Oct 30, 2020	SELL	$57.43 - $63.64 $196,180 - $217,394	-3,416 Reduced 2.47%	135,086 $8.14 Million
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $12.8 Million - $15 Million	-233,726 Reduced 62.79%	138,502 $8.14 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $587,145 - $853,259	-12,654 Reduced 3.29%	372,228 $20.7 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $6.74 Million - $8.79 Million	136,917 Added 55.22%	384,882 $24.7 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $866,691 - $1.03 Million	20,264 Added 8.9%	247,965 $12.6 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $22,756 - $25,163	-510 Reduced 0.22%	227,701 $10.3 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $248,791 - $296,653	5,514 Added 2.48%	228,211 $10.9 Million
Q4 2018 Feb 15, 2019	SELL	$48.76 - $63.23 $253,405 - $328,606	-5,197 Reduced 2.28%	222,697 $11.6 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $360,445 - $406,554	-6,531 Reduced 2.79%	227,894 $14.1 Million
Q2 2018 Jul 18, 2018	BUY	$50.53 - $62.98 $586,249 - $730,693	11,602 Added 5.21%	234,425 $13 Million
Q1 2018 May 22, 2018	BUY	$59.92 - $68.98 $618,314 - $711,804	10,319 Added 4.86%	222,823 $14.1 Million
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $1.12 Million - $1.22 Million	18,698 Added 9.65%	212,504 $13 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $10.7 Million - $12.4 Million	193,806	193,806 $12.4 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Bristol Myers Squibb CO Transaction History